Showing results (1-10 of 1,271) with videos related to
Sort By:
Pageof 128
Nephrology (Carlton, Vic.)|July 20, 2007
Erythropoiesis-stimulating agent hyporesponsivenessDavid W Johnson, Carol A Pollock, Iain C MacdougallAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 24, 2011
New anemia therapies: translating novel strategies from bench to bedsideIain C MacdougallNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 14, 2005
Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risksIain C MacdougallNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2004
Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients?Iain C MacdougallNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2005
Adverse event issue management: what have we learnt from pure red cell aplasia (PRCA)?Iain C MacdougallClinical Journal of the American Society of Nephrology : CJASN|December 14, 2007
Novel erythropoiesis-stimulating agents: a new era in anemia managementIain C MacdougallCurrent Hematology Reports|October 20, 2005
CERA (Continuous Erythropoietin Receptor Activator): a new erythropoiesis-stimulating agent for the treatment of anemiaIain C MacdougallContributions to Nephrology|May 25, 2006
How to optimise anaemia therapy in peritoneal dialysis patientsIain C MacdougallClinical Kidney Journal|December 12, 2017
Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directionsIain C MacdougallJournal of Renal Care|November 7, 2009
Evolution of iv iron compounds over the last centuryIain C MacdougallPageof 128